Determinants of survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 therapy

BACKGROUND: The present study aimed to investigate the determinant factors of survival in patients with pretreated advanced stage non-small cell lung cancer (NSCLC) who received anti-PD-1/PD-L1 therapy. METHODS: In this observational retrospective study, the clinical profiles and laboratory paramete...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Wael Abdullah Sultan, Hui, Pan, Ma, Yuxiang, Wu, Yuehan, Zhang, Yang, Chen, Yukun, Hong, Shaodong, Yang, Yunpeng, Huang, Yan, Zhao, Yuanyuan, Fang, Wenfeng, Zhao, Hongyun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667098/
https://www.ncbi.nlm.nih.gov/pubmed/34988148
http://dx.doi.org/10.21037/atm-21-1702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667098/
https://www.ncbi.nlm.nih.gov/pubmed/34988148
http://dx.doi.org/10.21037/atm-21-1702

Ejemplares similares